IMMNOV — Immunovia AB (publ) Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual balance sheet for Immunovia AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	263	468	287	106	76.8
Net Total Accounts Receivable
Net Total Receivables	3.41	4.35	4.48	3.65	3.72
Total Inventory
Prepaid Expenses
Total Current Assets	269	475	297	116	80.5
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	55.2	48.7	46.5	47.9	15.1
Net Intangible Assets
Long Term Investments
Total Assets	419	661	494	301	98.7
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	28.6	33.8	32.8	24.1	29.9
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	61.8	61.8	59.9	56.8	31.7
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	358	599	434	244	67
Total Liabilities & Shareholders' Equity	419	661	494	301	98.7
Total Common Shares Outstanding